Liquid Biopsy
News and reporting on cell-free DNA testing.
Cancer Diagnostics Firm Syantra Raises $3.6M in Series A-1 Round
The University of Calgary spinout aims to commercialize a liquid biopsy test that measures mRNA biomarkers for the early detection of breast cancer.
Pillar Biosciences, AstraZeneca Partner on Liquid Biopsy Testing in Europe
AstraZeneca has partnered with several other firms on liquid biopsies, including Angle, Sophia Genetics, IMBdx, and Guardant Health.
Italian Hospital System to Offer Guardant360 CDx Liquid Biopsy Service for Cancer Therapy Selection
Rome-based Policlinico Gemelli will establish an in-house liquid biopsy testing service within its hospital system utilizing Guardant360 CDx.
Micronbrane Medical Inks European Distribution Deal for Pathogen Detection Products
The deal includes Micronbrane's PaRTI-Seq assay for the identification of pathogens and other microbes.
A. Menarini Gets European Rights to Nucleix Bladder Cancer Test
The CE-marked and FDA-cleared test analyzes disease-specific changes in 15 DNA methylation markers in urine using qPCR.